Manfredi Rizzo is former Director, Clinical Medical & Regulatory Department, Novo Nordisk Europe East and South and has given lectures, received honoraria and research support, and participated in conferences, advisory boards and clinical trials sponsored by pharmaceutical industry including Amgen, AstraZeneca, Boehringer Ingelheim, Kowa, Eli Lilly, Meda, Mylan, Merck Sharp & Dohme, Novo Nordisk, Novartis, Roche Diagnostics, Sanofi and Servier
It means that most Aetna commercial plan members can no longer receive Zepbound for obesity management at standard formulary rates
PlexusDx supports ongoing therapy with flat monthly pricing ($189/mo for compounded semaglutide injection) to make sustained weight loss accessible
At Perfect Skin Solutions, we are seeing a rising number of patients concerned about Ozempic face a term describing the rapid facial volume loss, skin sagging, and hollowed appearance some experience with GLP-1 agonists
Vitamin B12 injections, or B12 shots, deliver a concentrated dose of Vitamin B12 directly into the bloodstream through an intramuscular injection